Morgan Stanley raised the firm’s price target on Humana (HUM) to $290 from $285 and keeps an Equal Weight rating on the shares. While policy ...

The company updated its guidance for 2025, projecting low single-digit loan growth, with most growth occurring in the second half of the year. The Sabal Trust acquisition is expected to contribute to ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Humana is part of the Health Care sector, which has an average P/E ratio of 26.07 and an average P/B of 3.53 Humana has on average reported free cash flows of $3.16 Billion over the last four years, ...